Virginia Cancer Specialists Welcomes Medical Oncologist, Kevin Diasti, MD, to Meet the Growing Demand in Western Fairfax County and Loudoun County, Virginia
Virginia Cancer Specialists, named #1 physician practice in Virginia for cancer by Castle Connolly, which represents the top 7% of all practicing physicians nationwide, is devoted to fighting cancer and diseases of the blood by offering access to the most current treatment protocols, largest clinical trial portfolio in the Mid-Atlantic, and comprehensive, compassionate care, all available […]
New Treatment Breakthrough: Amivantamab Plus Lazertinib for Advanced Lung Cancer – Timothy A. McCarthy, MD
A groundbreaking study published in June 2024 in The New England Journal of Medicine has introduced a promising new treatment for a specific type of advanced lung cancer. The research, co-authored by Alex Spira, MD, PhD, FACP, FACSO, Medical Oncologist and Co-Director of The Virginia Cancer Specialists Research Institute, highlights the combination of two drugs, […]
Unlocking Hope: Celebrating Clinical Trials Week with Virginia Cancer Specialists
As we celebrate Clinical Trials Week, we honor the remarkable journey of discovery and innovation that clinical trials represent in the realm of cancer research. At Virginia Cancer Specialists, we stand as a beacon of hope, leading the charge in pioneering breakthrough treatments and shaping the future of oncology care. A Legacy of Excellence: […]
Lymphedema Awareness Month -Shedding Light on Breast Cancer-Related Arm Lymphedema: A Call for Awareness and Action
Lymphedema Awareness Month – Part 1 March is a time dedicated to raising awareness about lymphedema, a condition that affects millions worldwide. Among the various forms of lymphedema, breast cancer-related arm lymphedema (BCRAL) stands out as a significant concern, impacting up to 20% of breast cancer survivors. As we mark Lymphedema Awareness Month, it’s crucial […]
Dr. Mitul Gandhi, Medical Oncologist at Virginia Cancer Specialists, Co-Authors Real-World Study Assessing Efficacy of Azacitidine in Treatment-Naive Patients with Higher-Risk Myelodysplastic Syndromes
Dr. Mitul Gandhi, Medical Oncologist at Virginia Cancer Specialists, Co-Authors Real-World Study Assessing Efficacy of Azacitidine in Treatment-Naive Patients with Higher-Risk Myelodysplastic Syndromes This study highlights the need for new therapies that improve complete remission and survival rates in patients with HR-MDS. Fairfax, Virginia, February 9, 2024 – Virginia Cancer Specialists, a premier provider of […]
Revolutionizing Breast Cancer Care: Insights and Recommendations from a Pivotal Germline Mutation Testing Study
Dr. Patricia Rodriguez of Virginia Cancer Specialists, is a co-author of the joint guideline paper issued by the American Society of Clinical Oncology (ASCO) and the Society of Surgical Oncology (SSO) that aims to provide evidence-based recommendations for healthcare professionals dealing with precision care for breast cancer patients. The main goal of this paper was […]
Abemaciclib in the Treatment of Early-Stage Hormone Receptor-Positive Breast Cancer – Anmol Singh, MD
Endocrine therapy remains a mainstay in the treatment of early-stage hormone receptor-positive breast cancer. However, oncologists continue to work on improving the risk of recurrence in patients whose tumors exhibit high-risk features, such as a larger size or lymph node involvement. The MonarchE trial, a randomized phase 3 trial in adults, examined how the addition […]
Brentuximab Vedotin: A Promising Frontline Therapy for Older Hodgkin Lymphoma Patients
A recent study published by Dr. Dipti Patel-Donnelly, of Virginia Cancer Specialists and colleagues has shed light on a groundbreaking approach in the treatment of advanced-stage classical Hodgkin lymphoma (cHL) in older patients. This noncomparative phase 2 study, detailed in the research article here, explores the efficacy of brentuximab vedotin (BV) in combination with dacarbazine […]
Enhancing Lung Cancer Treatment: The Promise of Perioperative Immunotherapy – Samantha DiBenedetto, MD
Introduction: Lung cancer remains one of the most challenging and life-threatening diseases; however, several exciting treatment advances show promising benefits. A recent study in which Virginia Cancer Specialists participated under the research leadership of Dr. Alex Spira, the AEGEAN trial, was published in the New England Journal of Medicine (NEJM) earlier this month and has shed light […]
The Potential of Multicancer Early Detection Blood Tests: The PATHFINDER Study
Detecting cancer at an early, treatable stage remains challenging, but new technologies are offering hope. The PATHFINDER study <Blood-based tests for multicancer early detection (PATHFINDER): a prospective cohort study>, conducted by a team of experts including Deb Schrag MD, Tomasz M. Beer MD, Charles H. McDonnell III MD and Robert Reid MD (of Virginia Cancer […]